Époétine bêta dans le traitement de l'anémie liée à la chimiothérapie dans les tumeurs solides et les hémopathies malignes. Résultats d'un essai clinique, en ouvert, multicentrique = Epoetin beta for the treatment of chemotherapy-induced anaemia in solid and haematological malignancies. Results of an open-label, multicentric clinical trialSPAËTH, D.Bulletin du cancer. 2010, Vol 97, Num 8, pp 969-978, issn 0007-4551, 10 p.Article

Epoetin beta (neorecormon®) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy : a meta-analysisBOOGAERTS, M; OBERHOFF, C; TEN BOKKEL HUININK, W et al.Anticancer research. 2006, Vol 26, Num 1B, pp 479-484, issn 0250-7005, 6 p.Article

Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer : a meta-analysisAAPRO, M; COIFFIER, B; DUNST, J et al.British journal of cancer. 2006, Vol 95, Num 11, pp 1467-1473, issn 0007-0920, 7 p.Article

Anaemia management strategies : Optimising treatment using epoetin beta (NeoRecormon®)GLASPY, John; BEGUIN, Yves.Oncology. 2005, Vol 69, pp 8-16, issn 0030-2414, 9 p., SUP2Conference Paper

Evolving treatment strategies for anaemia in cancer: Experience with epoetin betaAAPRO, Matti; SAN MIGUEL, Jésus.Oncology. 2004, Vol 67, pp 17-22, issn 0030-2414, 6 p., SUP1Conference Paper

Epoetin beta therapy in patients with solid tumoursPRONZATO, Paolo; JASSEM, Jacek; MAYORDOMO, Jose et al.Critical reviews in oncology/hematology. 2006, Vol 58, Num 1, pp 46-52, issn 1040-8428, 7 p.Article

Evaluating erythropoietic agents for the treatment of anaemia in the oncology settingGASCON, Pere.European journal of cancer (1990). 2005, Vol 41, Num 17, pp 2601-2612, issn 0959-8049, 12 p.Article

New guidelines on anaemia management in patients with cancer : How do these affect clinical practice?BIRGEGARD, Gunnar; BOKEMEYER, Carsten.Oncology. 2005, Vol 69, pp 17-21, issn 0030-2414, 5 p., SUP2Conference Paper

The role of epoetin beta in the treatment of anaemia in patients with gynaecological malignanciesCORNES, P; BOIANGIU, I.Anticancer research. 2007, Vol 27, Num 1B, pp 513-522, issn 0250-7005, 10 p.Article

Prise en charge de l'anémie des patients hémodialysés en France: résultats de l'étude DiaNE à trois ans (DiaNE 2) = Anemia management in French hemodialysis patients: DiaNE study results at 3 years (DiaNE2)KESSLER, Michèle; LANDAIS, Paul; BATAILLE, Pierre et al.Néphrologie & thérapeutique. 2011, Vol 7, Num 3, pp 182-187, issn 1769-7255, 6 p.Article

Recombinant erythropoietin differently affects proliferation of mesothelioma cells but not sensitivity to cisplatin and pemetrexedPALUMBO, Camilla; BATTISTI, Sonia; CARBONE, Daniela et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 5, pp 893-901, issn 0344-5704, 9 p.Article

Effective treatment of anemia in pediatric kidney transplant recipients with methoxy polyethylene glycol-epoetin betaWEDEKIN, Mirja; EHRICH, Jochen H. H; PAPE, Lars et al.Pediatric transplantation. 2011, Vol 15, Num 3, pp 329-333, issn 1397-3142, 5 p.Article

Efficacité de l'époétine bêta hebdomadaire dans l'anémie des tumeurs solides sous chimiothérapie = Efficacy of Weekly Epoetin Beta in the Treatment of Chemotherapy-Induced Anemia in Solid TumorsOUDARD, Stéphane; QUOIX, Elisabeth; JENABIAN, Arash et al.Thérapie (Paris). 2009, Vol 64, Num 1, pp 17-25, issn 0040-5957, 9 p.Article

Epoetin beta pegol (C.E.R.A.) promotes utilization of iron for erythropoiesis through intensive suppression of serum hepcidin levels in miceSASAKI, Yusuke; NOGUCHI-SASAKI, Mariko; MATSUO-TEZUKA, Yukari et al.International journal of hematology. 2014, Vol 99, Num 5, pp 561-569, issn 0925-5710, 9 p.Article

Pharmacokinetic analysis of subcutaneous erythropoietin administration with nonlinear mixed effect model including endogenous productionHAYASHI, N; KINOSHITA, H; YUKAWA, E et al.British journal of clinical pharmacology. 1998, Vol 46, Num 1, pp 11-19, issn 0306-5251Article

Darbepoetin alpha in lower-than-equimolar doses maintains haemoglobin levels in stable haemodialysis patients converting from epoetin alpha/betaBOCK, H. Andreas; HIRT-MINKOWSKI, Patricia; BRÜNISHOLZ, Michel et al.Nephrology, dialysis, transplantation (Print). 2008, Vol 23, Num 1, pp 301-308, issn 0931-0509, 8 p.Article

méthoxy polyéthylène glycol-époétine bêta ^(Mircera°) : ÉPOÉTINE BÊTA PÉGYLÉE : GARE AUX TROUBLES CARDIOVASCULAIRES = Methoxypolyethyleneglycol-epoietin beta or pegylated epoietin beta : risks of cardiovascular disordersLa Revue Prescrire. 2008, Vol 28, Num 294, pp 247-247, issn 0247-7750, 1 p.Article

Once-every-2-weeks and once-weekly epoetin beta regimens : Equivalency in hemodialyzed patientsMIRCESCU, Gabriel; GARNEATA, Liliana; CONSTANTINOVICI, Niculae et al.American journal of kidney diseases. 2006, Vol 48, Num 3, pp 445-455, issn 0272-6386, 11 p.Article

Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin productionCAZZOLA, Mario; BEGUIN, Yves; KLOCZKO, Janusz et al.British journal of haematology. 2003, Vol 122, Num 3, pp 386-393, issn 0007-1048, 8 p.Article

A study of the response of elderly patients with end-stage Renal disease to epoetin alfa or betaNICHOLAS, Johann C. B.Drugs & aging. 2004, Vol 21, Num 3, pp 187-201, issn 1170-229X, 15 p.Article

Clinical and economic impact of epoetins in cancer careMARCHETTI, Monia; BAROSI, Giovanni.PharmacoEconomics (Auckland). 2004, Vol 22, Num 16, pp 1029-1045, issn 1170-7690, 17 p.Article

Subcutaneous low-dose epoetin beta for the avoidance of transfusion in patients scheduled for elective surgery not eligible for autologous blood donationWURNIG, C; SCHATZ, K; NOSKE, H et al.European surgical research. 2001, Vol 33, Num 5-6, pp 303-310, issn 0014-312XArticle

Urinary Loss of Erythropoietin after Intravenous Versus Subcutaneous Epoetin-beta in Preterm InfantsLANGER, Juliane; OBLADEN, Michael; DAME, Christof et al.The Journal of pediatrics. 2008, Vol 152, Num 5, pp 728-730, issn 0022-3476, 3 p.Article

L'époétine bêta, de nouvelles stratégies pour optimiser la prise en charge de l'anémie des patients cancéreux = Epoetin beta, new strategies to optimise the management of anaemia in cancer patientsSOLIGNAC, Marie.La Presse médicale (1983). 2003, Vol 32, Num 29, pp 1385-1388, issn 0755-4982, 4 p.Article

Gentechnische Herstellung von Arzneimitteln und ihre Anwendung am Beispiel des Erythropoetins = Genetically engineered drugs and their application of recombinant erythropoietinDONATZ, V; ZAHNER, J.AINS. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 2001, Vol 36, Num 7, pp 440-444, issn 0939-2661Article